Treatment of Vertigo | |
| AGENTa | DOSEb |
|---|---|
| Antihistamines | |
| Meclizine | 25-50 mg 3 times daily |
| Dimenhydrinate | 50 mg 1-2 times daily |
| Promethazine | 25 mg 2-3 times daily (also can be given rectally and IM) |
| Benzodiazepines | |
| Diazepam | 2.5 mg 1-3 times daily |
| Clonazepam | 0.25 mg 1-3 times daily |
| Anticholinergic | |
| Scopolamine transdermalc | Patch |
| Physical therapy | |
| Repositioning maneuversd | |
| Vestibular rehabilitation | |
| Other | |
| Diuretics and/or low-sodium (1000 mg/d) diete | |
| Antimigrainous drugsf | |
| Methylprednisoloneg | 100 mg daily days 1-3; 80 mg daily days 4-6; 60 mg daily days 7-9; 40 mg daily days 10-12; 20 mg daily days 13-15; 10 mg daily days 16-18, 20, 22 |
| Selective serotonin reuptake inhibitorsh | |
a All listed drugs are approved by the U.S. Food and Drug Administration, but most are not approved for the treatment of vertigo.
b Usual oral (unless otherwise stated) starting dose in adults; a higher maintenance dose can be reached by a gradual increase.
c For motion sickness only.
d For benign paroxysmal positional vertigo.
f For vestibular migraine.
g For acute vestibular neuritis (started within 3 days of onset).